Curis (CRIS) Misses Q4 EPS by 2c

Curis (NASDAQ: CRIS) reported Q4 EPS of ($0.15), $0.02 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $3.1 million versus the consensus estimate of $2.96 million.

As of December 31, 2021, Curis's cash, cash equivalents and investments totaled $139.8 million, and there were approximately 91.6 million shares of common stock outstanding. Curis expects that its existing cash, cash equivalents and investments should enable it to maintain its planned operations into 2024.

For earnings history and earnings-related data on Curis (CRIS) click here.

You May Also Be Interested In

• Coherent posts a blowout Q4 and aggressive guidance, yet shares take a 5% haircut
• EnerSys (ENS) Tops Q1 EPS by 84c; offers guidance
• BioStem Technologies, Inc. (BSEM) Misses Q3 EPS by 44c; offers guidance